Vesnarinone

This classification denotes a phosphodiesterase inhibitor and antineoplastic antibiotic with the molecular formula C22H25N3O4, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 5COW40EV8M, chemically known as 3,4-dihydro-6-(4-(3,4-dimethoxybenzoyl)-1-piperazinyl)-2(1h)-quinolinone but generally known as vesnarinone, which bears US NIH Compound Identifier 5663. European Medicines Agency schedules Vesnarinone in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB00045MIG. The term VESNARINONE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 1, No. 4, 1987, List 27). VESNARINONE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule Vesnarinone under HS 29337900 and SITC 51561. As of Q4 2014, VESNARINONE remains the US FDA Preferred Term for this commodity. Vesnarinone bears US NLM identifiers UMLS ID C0148345 and NCI Concept Code C1415. SMILES: COC1CCC(CC1OC)C(=O)N2CCN(CC2)C3CCC4C(C3)CCC(=O)N4.